Related Experiment Videos
Poor recruitment to lung cancer trials
BMJ (Clinical Research Ed.)
|March 29, 1997
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer.
Gynecologic oncology·2016
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Bevacizumab and ovarian cancer.
Drugs of today (Barcelona, Spain : 1998)·2011